BR112013000675A2 - nanopartícula, processo para produzir uma nanopartícula compreendendo uma matriz de zeína e um aminoácido básico, processo para produzir uma nanopartícula compreendendo uma matriz de zeína, e um aminoácido básico e um composto biologicamente ativo solúvel em gordura, composição e produto alimentar - Google Patents
nanopartícula, processo para produzir uma nanopartícula compreendendo uma matriz de zeína e um aminoácido básico, processo para produzir uma nanopartícula compreendendo uma matriz de zeína, e um aminoácido básico e um composto biologicamente ativo solúvel em gordura, composição e produto alimentarInfo
- Publication number
- BR112013000675A2 BR112013000675A2 BR112013000675A BR112013000675A BR112013000675A2 BR 112013000675 A2 BR112013000675 A2 BR 112013000675A2 BR 112013000675 A BR112013000675 A BR 112013000675A BR 112013000675 A BR112013000675 A BR 112013000675A BR 112013000675 A2 BR112013000675 A2 BR 112013000675A2
- Authority
- BR
- Brazil
- Prior art keywords
- nanoparticle
- amino acid
- basic amino
- producing
- zein matrix
- Prior art date
Links
- 239000002105 nanoparticle Substances 0.000 title abstract 9
- 150000001413 amino acids Chemical class 0.000 title abstract 5
- 239000011159 matrix material Substances 0.000 title abstract 5
- 229920002494 Zein Polymers 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000005019 zein Substances 0.000 title abstract 4
- 229940093612 zein Drugs 0.000 title abstract 4
- 235000013305 food Nutrition 0.000 title abstract 3
- 239000002537 cosmetic Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5169—Proteins, e.g. albumin, gelatin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S264/00—Plastic and nonmetallic article shaping or treating: processes
- Y10S264/59—Processes in which a partial cure is involved
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Peptides Or Proteins (AREA)
- General Preparation And Processing Of Foods (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201031095 | 2010-07-16 | ||
ESP201031095 | 2010-07-16 | ||
PCT/ES2011/070518 WO2012007628A1 (es) | 2010-07-16 | 2011-07-15 | Nanopartículas para encapsulación de compuestos, su obtención y usos |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112013000675A2 true BR112013000675A2 (pt) | 2016-05-31 |
BR112013000675B1 BR112013000675B1 (pt) | 2021-07-20 |
Family
ID=44764176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013000675-7A BR112013000675B1 (pt) | 2010-07-16 | 2011-07-15 | Nanopartícula, processo para produzir uma nanopartícula compreendendo uma matriz de zeína e um aminoácido básico, composição e produto alimentar |
Country Status (14)
Country | Link |
---|---|
US (1) | US9381252B2 (pt) |
EP (1) | EP2594140B1 (pt) |
JP (1) | JP6046615B2 (pt) |
KR (1) | KR101933024B1 (pt) |
CN (1) | CN103037707B (pt) |
AU (1) | AU2011278186B2 (pt) |
BR (1) | BR112013000675B1 (pt) |
CA (1) | CA2805581C (pt) |
DK (1) | DK2594140T3 (pt) |
ES (1) | ES2724176T3 (pt) |
MX (1) | MX338891B (pt) |
PL (1) | PL2594140T3 (pt) |
PT (1) | PT2594140T (pt) |
WO (1) | WO2012007628A1 (pt) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2625966A1 (en) * | 2012-02-13 | 2013-08-14 | Bionanoplus, S.L. | Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof |
JP6235779B2 (ja) * | 2012-03-28 | 2017-11-22 | 株式会社コーセー | 葉酸含有組成物及び葉酸の安定化方法 |
KR101362800B1 (ko) * | 2012-10-16 | 2014-02-14 | 한국식품연구원 | 피토스테롤이 함유된 프롤라민-양이온 폴리머 복합체 및 이의 제조방법 |
GB201312245D0 (en) * | 2013-07-08 | 2013-08-21 | Gorman Eddie O | An extrusion process |
EP2856987A1 (en) | 2013-10-07 | 2015-04-08 | Absorbest AB | A wound dressing and a method for manufacturing a wound dressing |
WO2016025394A2 (en) | 2014-08-11 | 2016-02-18 | Board Of Supervisors Of Louisiana State University And Agriculatural And Mechanical College | Delivery of bioactive, nanoencapsulated antioxidants |
MX2017013557A (es) | 2015-04-22 | 2018-02-26 | Basf Se | Nanoparticulas, nanoemulsiones y su formacion con micronizacion en camara de mezcla. |
CN108308615A (zh) * | 2018-01-12 | 2018-07-24 | 齐齐哈尔大学 | 一种玉米肽为载体的叶黄素纳米粒的制备方法 |
CN108576501B (zh) * | 2018-01-18 | 2021-07-02 | 广东药科大学 | 一种植物多酚类功能饮料的制备方法 |
EP3581176A1 (en) | 2018-06-12 | 2019-12-18 | Universidad de Navarra | Core-shell zein nanoparticles for the encapsulation of compounds, process for their preparation and uses thereof |
CN112535212A (zh) * | 2019-09-20 | 2021-03-23 | 内蒙古伊利实业集团股份有限公司 | 儿茶素原料的预处理方法以及包含儿茶素的果汁牛奶 |
CN111893584B (zh) * | 2020-06-16 | 2021-06-22 | 杭州千芝雅卫生用品有限公司 | 耐水性环保纤维滤材及其制备方法 |
CN112370419A (zh) * | 2020-10-16 | 2021-02-19 | 江苏大学 | 一种醇溶性蛋白、氨基酸或/和多糖协同稳定的Pickering乳液凝胶的制备方法 |
WO2022136393A1 (en) | 2020-12-23 | 2022-06-30 | Universidad De Navarra | Zein nanoparticles for use in hyperglycemic conditions |
CN113244193A (zh) * | 2021-04-26 | 2021-08-13 | 南京大学 | 用于递送甾醇及其衍生物的蛋白纳米粒的制法与应用 |
CN114129538B (zh) * | 2021-10-26 | 2022-12-09 | 浙江科技学院 | 一种负载藏红花素玉米醇溶蛋白纳米颗粒的制备方法及应用 |
WO2023086572A2 (en) * | 2021-11-12 | 2023-05-19 | Tolan Naomie Lucas | Combinations of nanoparticle-encapsulated cargo entities and methods for making and using same |
WO2023154838A2 (en) * | 2022-02-11 | 2023-08-17 | Arizona Board Of Regents On Behalf Of Arizona State University | Antimicrobial materials and nanoparticles and methods of use thereof |
US11559495B1 (en) * | 2022-03-07 | 2023-01-24 | King Abdulaziz University | Icariin nano-pharmaceutical formulation |
CN114796155B (zh) * | 2022-03-31 | 2023-06-27 | 诺丁汉大学卓越灯塔计划(宁波)创新研究院 | 天然活性物质-玉米蛋白纳米颗粒及其制备方法和用途 |
CN116172115B (zh) * | 2022-12-05 | 2024-05-14 | 西北农林科技大学 | 通过添加L-Lys改善高剂量EGCG对肉蛋白凝胶特性损伤的方法 |
CN116333079B (zh) * | 2023-03-07 | 2023-09-15 | 中国农业科学院农产品加工研究所 | 一种用叶酸修饰的玉米醇溶蛋白及其制备方法和应用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0550436A1 (en) * | 1989-11-06 | 1993-07-14 | Alkermes Controlled Therapeutics, Inc. | Protein microspheres and methods of using them |
JP3790567B2 (ja) * | 1994-09-30 | 2006-06-28 | 武田薬品工業株式会社 | 徐放剤 |
FR2824756B1 (fr) | 2001-05-16 | 2005-07-08 | Mainelab | Microcapsules a base de proteines vegetales |
US20040086595A1 (en) | 2002-10-31 | 2004-05-06 | Jingping Liu | Plasticized prolamine compositions |
CN1717180A (zh) * | 2002-11-29 | 2006-01-04 | 服洛因得产业股份有限公司 | 水性虫胶包膜材料、其制造方法、使用该包膜材料的包膜食品、其制造方法、包膜医药品、其制造方法、油性糖果的着色用组合物、着色方法、及着色油性糖果 |
JP2004269384A (ja) * | 2003-03-06 | 2004-09-30 | Kyowa Hakko Kogyo Co Ltd | 吸水性アミノ酸被覆顆粒 |
CN1476825A (zh) * | 2003-07-04 | 2004-02-25 | 中国科学院上海有机化学研究所 | 谷物类醇溶蛋白微球和制备方法 |
CA2548992A1 (en) | 2003-12-11 | 2005-08-11 | Vaxdesign Corporation | Immunotherapy compositions, method of making and method of use thereof |
CN1562373A (zh) * | 2004-03-25 | 2005-01-12 | 上海交通大学 | 植物源性醇溶蛋白微球固体剂型的制备方法 |
MX2008003213A (es) | 2005-09-09 | 2008-03-18 | Kellog Co | Acidos grasos omega-3 encapsulados en recubrimientos de zeina y productos alimenticios que los incorporan. |
ES2564241T3 (es) * | 2005-12-02 | 2016-03-21 | Glaxosmithkline Biologicals Sa | Nanopartículas para su uso en composiciones inmunogénicas |
US20080305096A1 (en) | 2007-06-07 | 2008-12-11 | Unicity International, Inc. | Method and composition for providing controlled delivery of biologically active substances |
TWI437962B (zh) * | 2007-06-19 | 2014-05-21 | Dsm Ip Assets Bv | 微包封組成物、其製造方法、使用方法及其產物 |
CN201092514Y (zh) | 2007-06-25 | 2008-07-30 | 上海港机重工有限公司 | 双起升式集装箱起重机运行小车的吊具上架限位装置 |
CN100540608C (zh) * | 2007-07-20 | 2009-09-16 | 浙江大学 | 谷类蛋白质/纳米粒子原位复合材料及其制备方法 |
EP2214747A2 (en) | 2007-11-20 | 2010-08-11 | Cook Incorporated | Controlled drug delivery using a zein layer modified with levulinic acid |
CN101485629B (zh) | 2008-01-16 | 2013-01-23 | 沈阳药科大学 | 一种给药系统及其制备方法 |
KR101616771B1 (ko) * | 2008-05-09 | 2016-04-29 | 사우스다코타주립대학 | 비면역원성의 소수성 단백질 나노입자의 형성방법 및 그 용도 |
-
2011
- 2011-07-15 CN CN201180035074.3A patent/CN103037707B/zh active Active
- 2011-07-15 PT PT11767022T patent/PT2594140T/pt unknown
- 2011-07-15 EP EP11767022.4A patent/EP2594140B1/en active Active
- 2011-07-15 ES ES11767022T patent/ES2724176T3/es active Active
- 2011-07-15 AU AU2011278186A patent/AU2011278186B2/en active Active
- 2011-07-15 WO PCT/ES2011/070518 patent/WO2012007628A1/es active Application Filing
- 2011-07-15 US US13/809,089 patent/US9381252B2/en active Active
- 2011-07-15 BR BR112013000675-7A patent/BR112013000675B1/pt active IP Right Grant
- 2011-07-15 DK DK11767022.4T patent/DK2594140T3/da active
- 2011-07-15 PL PL11767022T patent/PL2594140T3/pl unknown
- 2011-07-15 JP JP2013519119A patent/JP6046615B2/ja active Active
- 2011-07-15 KR KR1020137003896A patent/KR101933024B1/ko active IP Right Grant
- 2011-07-15 CA CA2805581A patent/CA2805581C/en active Active
- 2011-07-15 MX MX2013000636A patent/MX338891B/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CN103037707A (zh) | 2013-04-10 |
JP6046615B2 (ja) | 2016-12-21 |
MX2013000636A (es) | 2013-05-31 |
EP2594140B1 (en) | 2019-03-20 |
KR101933024B1 (ko) | 2018-12-27 |
KR20130045358A (ko) | 2013-05-03 |
CN103037707B (zh) | 2016-08-31 |
AU2011278186B2 (en) | 2015-02-05 |
DK2594140T3 (da) | 2019-06-03 |
US9381252B2 (en) | 2016-07-05 |
BR112013000675B1 (pt) | 2021-07-20 |
US20130116261A1 (en) | 2013-05-09 |
PL2594140T3 (pl) | 2019-09-30 |
AU2011278186A1 (en) | 2013-01-31 |
MX338891B (es) | 2016-05-04 |
ES2724176T3 (es) | 2019-09-06 |
PT2594140T (pt) | 2019-06-11 |
CA2805581A1 (en) | 2012-01-19 |
JP2013532630A (ja) | 2013-08-19 |
CA2805581C (en) | 2018-10-02 |
WO2012007628A1 (es) | 2012-01-19 |
EP2594140A1 (en) | 2013-05-22 |
RU2013106946A (ru) | 2014-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013000675A2 (pt) | nanopartícula, processo para produzir uma nanopartícula compreendendo uma matriz de zeína e um aminoácido básico, processo para produzir uma nanopartícula compreendendo uma matriz de zeína, e um aminoácido básico e um composto biologicamente ativo solúvel em gordura, composição e produto alimentar | |
BR112012021372A2 (pt) | nanopartícula, processo para produção de nanopartículas, composição e gênero alimentício | |
BR112015000041A2 (pt) | micropartícula, método para a obtenção das micropartículas definidas, composição, produto alimentar, farmacêutico, cosmecêutico ou nutracêutico e uso de uma micropartícula | |
BR112014002757A2 (pt) | encapsulados | |
CO6531471A2 (es) | Cápsulas resistentes a ácido | |
WO2012104275A3 (en) | Nanoparticles delivery systems, preparation and uses thereof | |
BR112015011112A2 (pt) | composto oligomérico, oligômero, composição farmacêutica, uso do composto oligomérico, método de síntese de um composto oligomérico e método de tratamento de uma doença. | |
BR112014029247A2 (pt) | nanopartícula de lipídio, composição farmacêutica, método para fazer uma nanopartícula de lipído, produto, método de tratamento de um distúrbio, e sistema de entrega | |
CL2013001282A1 (es) | Sal succinato de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]-pirimidin-6-carboxilico; composicion farmaceutica que la comprende y procesos para su preparacion. | |
GT201200250A (es) | Ariltriazolonas ligadas a bisarilo y su uso | |
BR112012017737A8 (pt) | polivinilpirrolidona para a estabilização de uma dispersão sólida da forma não cristalina de rotigotina. | |
BR112014013175A8 (pt) | composições de liberação prolongada baseadas em lipídios anfipáticos e processo para preparar comprimidos de composição de liberação prolongada | |
BRPI0905733A2 (pt) | "composição, formulação farmacêutica, método para tratamento de câncer positivo para her2 e método pára a produção de uma composição farmacêutica" | |
BR112015012547A2 (pt) | composições de prostaciclina e métodos de sua utilização | |
BRPI0816320A2 (pt) | Composto, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto de combinação, e, processos para a preparação deu um composto, de uma formulação farmacêutica, e de um produto de combinação | |
CY1115595T1 (el) | Αλατα ρασιγιλινης και φαρμακευτικη παρασκευη αυτων | |
MX2011013726A (es) | Nanodispersión de un medicamento y proceso para su preparación. | |
BR112013002710A2 (pt) | nanocompósito de polímero compreendendo ácido poliláctico reforçado com o filossilicato modificado | |
BR112012015977A2 (pt) | composto derivado de poli (ácido lático), método para preparar o composto derivado de poli (ácido lático), complexo do composto de derivado de poli (ácido lático), composição de liberação prolongada de droga, e, método para preparar a composição de liberação prolongada de droga | |
BR112013024824A2 (pt) | ésteres isopentílicos para uso em composições cosméticas, dermatológicas ou farmacêuticas | |
IL227024A (en) | The 3 heteroarylamino propionic acid derivatives are converted into amino acids, a process for their preparation, their use in the preparation of medicinal preparations and as medical preparations containing them | |
EP2799438A4 (en) | FAT-SOLUBLE ANTICANCER DRUG COMPOUND, MODIFIED BY A WATER-SOLUBLE VITAMIN E DERIVATIVE, AND FORMULATION, PREPARATION METHOD AND USE THEREOF | |
BR112012030485A2 (pt) | composição para prevenção ou tratamento de osteoporose e processo de fabricação para a mesma | |
BR112014009242A8 (pt) | nanossuspensão farmacêutica | |
BR112014014021A2 (pt) | composição cosmética, produto para o tratamento da transpiração e processo para a produção de uma composição cosmética |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25G | Requested change of headquarter approved |
Owner name: UNIVERSIDAD DE NAVARRA (ES) , CENTRO NACIONAL DE T |
|
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 47/42 (2017.01), A23P 10/30 (2016.01), A61K 8 |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/07/2011, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |